🇳🇱

Netherlands for Biotech / Life Sciences

europeWorldwideBIOTECH / LIFE SCIENCES
59
Overall
57
BIOTECH
Industry Rank
#15of 27
Key Strength
Funding
Tax Regime
Worldwide
Verdict
Best For

Founders seeking capital - Netherlands's funding access (100/100) suits startups that need VC relationships and government co-investment programs.

Not Ideal For

Fully remote teams without local presence - Netherlands's remote infrastructure score (39/100) presents some limitations.

Bottom Line

Ranked #15 of 27 jurisdictions for Biotech / Life Sciences. Netherlands's Biotech / Life Sciences score of 57/100 is close to its overall score of 59/100, indicating balanced performance across dimensions.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Funding100

Strong funding environment for biotech / life sciences operators.

Practical100

Strong practical environment for biotech / life sciences operators.

Ecosystem100

Strong ecosystem environment for biotech / life sciences operators.

Watch Outs
Tax39

Lower tax score - verify current requirements carefully.

Remote39

Lower remote score - verify current requirements carefully.

Tax Res.45

Lower tax res. score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
25.8%
Corporate Tax
200
Active VCs
$4.2B
VC Deployed
Yes
Gov Grants
Yes
EU Funding
82
Talent Pool
Yes
IP Box Regime
5
Incorporation

Why Netherlands Works for Biotech / Life Sciences

Funding access (100/100) is a standout for Netherlands Biotech / Life Sciences companies. The local market has 200 active VC funds, with average seed checks of $1.5M. Government grant programs include WBSO (R&D Tax Credit) ($300K) and EIC Accelerator ($2.7M). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Startup ecosystem quality (100/100) is a key reason Netherlands ranks well for Biotech / Life Sciences. 12 unicorns have originated here, signalling institutional knowledge about building and scaling companies. Talent pool quality scores 82/100, and average senior developer salaries run $65K/year. Sector specializations relevant to Biotech / Life Sciences include: fintech, marketplace, logistics.

Operational ease (100/100) makes Netherlands practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated easy. Company formation takes approximately 5 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Watch Outs for Biotech / Life Sciences Founders in Netherlands

Remote infrastructure (39/100): Netherlands presents some limitations for fully remote teams. Connectivity, coworking density, or legal clarity for remote work may require additional planning for distributed Biotech / Life Sciences operations.

Corporate tax (39/100): Tax efficiency is not the primary reason to choose Netherlands for Biotech / Life Sciences operations. Founders whose primary goal is minimising the corporate tax line should model effective rates carefully and compare against jurisdictions with zero or near-zero corporate tax.

Personal tax (45/100): Personal income tax tops out at 49.5%, which is above-average for founder-friendly jurisdictions. The worldwide taxation system means all global income is taxable for residents. Founders planning high personal distributions should model after-tax take-home carefully against lower-tax alternatives.

Setup Requirements for Biotech / Life Sciences in Netherlands
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: easy access for foreign founders. Common options include ING, ABN AMRO, Rabobank.
  3. Formation: approximately 5 days to incorporate, estimated cost $2K plus annual compliance of $3K
  4. Timeline: 30 days visa processing + 5 days formation = approximately 35 days to be fully operational
  5. Visa pathway: Startup Visa (requirements vary by program, 12-month initial permit)
Industry Key Facts
Amsterdam - European HQ
EMA Location
Leiden Bio Science Park, Delft
Biotech Clusters
Applies to clinical research costs
WBSO on R&D
Higher than Eastern Europe but world-class quality
Clinical Trial Cost
Compare Netherlands vs Top Alternatives for Biotech / Life Sciences
🇳🇱Netherlands
57
🇩🇪Germany
64

Biotech / Life Sciences industry scores

🇳🇱Netherlands
57
🇮🇪Ireland
52

Biotech / Life Sciences industry scores

🇳🇱Netherlands
57
🇪🇪Estonia
68

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Netherlands good for Biotech / Life Sciences in 2026?

Netherlands ranks #15 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 57/100. The top strengths for Biotech / Life Sciences founders are funding access and startup ecosystem. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Netherlands?

Netherlands applies a statutory corporate tax rate of 25.8%, and an IP box regime at 9% for qualifying IP income. The jurisdiction has 100 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Netherlands have Biotech / Life Sciences-specific programs or incentives?

Netherlands is a premier European biotech jurisdiction. EMA (European Medicines Agency) is headquartered in Amsterdam. Yes!Delft and Leiden Bio Science Park are world-class biotech clusters. Clinical trials benefit from excellent hospital networks. WBSO applies to biotech R&D. Strong patent protection via Dutch and EU patent offices. Netherlands offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Netherlands compare to other jurisdictions for Biotech / Life Sciences?

Netherlands ranks #15 for Biotech / Life Sciences with 57/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by remote infrastructure, where Netherlands is weaker. Use NomadSignal's comparison pages to evaluate Netherlands head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.